Asterima Pharmaceuticals Private Limited

Asterima Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH2016PTC280401 Incorporated 30 April 2016 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹1.97 Cr
▲ 4% YoY
Net loss · FY 2025
₹5.74 Lakh
Net margin -2.9%
EBITDA · FY 2025
₹5.27 Lakh
EBITDA margin 2.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹6.18 Lakh
Issued & subscribed
Open charges
₹30 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
6
As per MCA filings

About Asterima Pharmaceuticals Private Limited

Data last updated:

Asterima Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 April 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2016PTC280401. Its GSTIN is 32AAOCA3432F1Z1 (Kerala).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6.18 Lakh. It is led by directors including Saneesh Methanath (Managing Director) and Mandeep Warrier.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.97 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net loss of ₹5.74 Lakh (net margin -2.9%) and EBITDA of ₹5.27 Lakh (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 53% over five years.

The company is associated with 1 brand: Asterima. As per MCA filings, the company has open charges of ₹30 Lakh on record.

Asterima Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0009874). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website asterima.com.

Company details

CIN U24230MH2016PTC280401
Registration Number 280401
Incorporation Date 30 April 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0009874

Recognitions & Rankings of Asterima Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-19-0009874

Contact details

Asterima Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is asterima.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    E – 309 Third Floor Crystal Plaza Opp.Infinity Mall Andheri Link Road An, Dheri West, Mumbai, Maharashtra, India – 400053
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Asterima Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Asterima Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Asterima Pharmaceuticals operates one associated brand: Asterima. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical innovation and quality-focused services in Mumbai.asterima.com

Business activity

The main business activity of Asterima Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Asterima Pharmaceuticals Private Limited, buy the company report.

Financials of Asterima Pharmaceuticals Private Limited

FY 2025 filings available

Asterima Pharmaceuticals Private Limited reported revenue of ₹1.97 Cr (up 4% YoY) for FY 2025.

Revenue · FY 2025
₹1.97 Cr ▲ 4%
Net loss · FY 2025
₹5.74 Lakh margin -2.9%
EBITDA · FY 2025
₹5.27 Lakh margin 2.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 22%
5 years · compounded
▲ 53%
EBITDA CAGR growth
1 year
▼ 61%
3 years · compounded
▲ 37%
5 years · compounded
▲ 42%

Revenue has grown at a compounded annual rate (CAGR) of 53% over five years, including 4% growth in the latest year. EBITDA fell 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹5.27 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹5.74 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.7%
Net Profit Margin-2.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Asterima Pharmaceuticals Private Limited, buy the company report.

Board of directors of Asterima Pharmaceuticals Private Limited

Asterima Pharmaceuticals has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Mandeep WarrierDirector10 Jul 20215 Years 3 MonthsCurrent
Soumya TomyDirector13 Dec 20223 Years 10 MonthsCurrent
Saneesh MethanathManaging Director30 Apr 201610 Years 5 MonthsCurrent
GirishDirector01 Oct 20215 Years 0 MonthsCurrent
ArunDirector01 Oct 20215 Years 0 MonthsCurrent
Sumesh MethanathDirector30 Apr 201610 Years 5 MonthsCurrent

Shareholding

The shareholding of Asterima Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Asterima Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹30 Lakh
Satisfied charges
None
Breakdown by lending institutions
Dhanlaxmi Bank Limited₹0.30 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Apr 2022100572713Dhanlaxmi Bank Limited₹30 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Asterima Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Asterima Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
32AAOCA3432F1Z1KeralaActive03 Jan 2018

To see the full GST registrations and return filing status of Asterima Pharmaceuticals Private Limited, buy the company report.

Recent activity

Asterima Pharmaceuticals Private Limited has 10 board changes on record since 2016: 6 appointments and 4 cessations. The latest: Diju Thottasseri Prabhakaran ceased to be Director on 29 Sep 2025.

AGM
Asterima Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Diju Thottasseri Prabhakaran ceased to be Director.
Ceased
Sandeep Prabhakaran ceased to be Director.
Filing
Asterima Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Soumya Tomy was appointed as Director.
Charges
A charge with Dhanlaxmi Bank Limited amounted to Rs. 30.00 Lakh with Charge ID 100572713 was registered on 20 Apr 2022.
Appointed
Arun was appointed as Director.
Appointed
Girish was appointed as Director.
Appointed
Mandeep Warrier was appointed as Director.
Ceased
Anitha Prabhakaran ceased to be Director.
Ceased
Prabhakaran Thottassery Krishnankutty ceased to be Director.
Appointed
Saneesh Methanath was appointed as Managing Director.

2 earlier events are in the company report.

Frequently asked questions

Asterima Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 April 2016 (10+ years old) and is registered under CIN U24230MH2016PTC280401.

Asterima Pharmaceuticals has 6 current directors:

The latest financial statements of Asterima Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Asterima Pharmaceuticals is 32AAOCA3432F1Z1, registered in Kerala.

The CIN (Corporate Identification Number) of Asterima Pharmaceuticals is U24230MH2016PTC280401. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Asterima Pharmaceuticals was incorporated on 30 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.

Diju Thottasseri Prabhakaran ceased to be Director on 29 Sep 2025. Sandeep Prabhakaran ceased to be Director on 29 Sep 2025. Soumya Tomy was appointed as Director on 13 Dec 2022. Asterima Pharmaceuticals has 10 board changes on record in total.

Yes, Asterima Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0009874).

Asterima Pharmaceuticals can be reached through the website asterima.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Asterima Pharmaceuticals is at E – 309 Third Floor Crystal Plaza Opp.Infinity Mall Andheri Link Road An, Dheri West, Mumbai, Maharashtra, India – 400053.